1、科研項(xiàng)目 (1) 國(guó)家自然科學(xué)基金委員會(huì), 面上項(xiàng)目, 82372009, 基于多源數(shù)據(jù)關(guān)聯(lián)分析的甲狀腺乳頭狀癌藥物重定位探索研究, 2024-01-01 至 2027-12-31, 50 萬元, 在研,主持 2、學(xué)術(shù)論文 (1) Overall survival and short-term efficacy analysis of cervical squamous cell carcinoma with skeletal muscle and 18 F-FDG PET/CT parameters, Scientific Reports, 2024,已錄用 (通訊作者) (2) Dynamic Immune Function Changes Before and After the First Radioactive Iodine Therapy After Total Resection of Differentiated Thyroid Carcinoma, Frontiers in immunology, 2022, 13(6): 901263(共同通訊作者) (3) Differential distribution and prognostic value of CD4+ T cell subsets before and after radioactive iodine therapy in differentiated thyroid cancer with varied curative outcomes, Frontiers in immunology, 2022,13(8): 966550 (共同通訊作者 ) (4) Absolute reduction in peripheral regulatory T cells in patients with Graves’ disease and post-treatment recovery, Molecular Immunology, 2022, 144(4): 49-57 (共同第一作者 ) 3、學(xué)術(shù)榮譽(yù):山西省新興產(chǎn)業(yè)領(lǐng)軍人才 4、科技獎(jiǎng)勵(lì) (1)劉海燕(6/8); PET 放射性藥物平臺(tái)建設(shè)及研發(fā)關(guān)鍵技術(shù)與應(yīng)用, 山西省科學(xué)技術(shù)獎(jiǎng)勵(lì)委員會(huì), 科技進(jìn)步, 省部二等獎(jiǎng), 2021 (2)劉海燕 (9/10); 心臟核醫(yī)學(xué)關(guān)鍵技術(shù)創(chuàng)新及推廣應(yīng)用, 山西省人民政府, 科技進(jìn)步, 省部一等獎(jiǎng), 2023 5、發(fā)明專利 (1)Sijin Li; Haiyan Liu; Gangqiang Zha; CZT semiconductor activity meter and activity measuring device, United States Patent, WO2020/142972 (2)劉海燕; 李思進(jìn); 移動(dòng)防輻射設(shè)備[P],專利發(fā)明,授權(quán)日:2018.12.26, 專利號(hào):ZL 201811601565.X 6、學(xué)術(shù)任職 (1)中華醫(yī)學(xué)會(huì)核醫(yī)學(xué)分會(huì),功能顯像組副組長(zhǎng),2023 年-2026 年 (2)中國(guó)醫(yī)師協(xié)會(huì)核醫(yī)學(xué)醫(yī)師分會(huì),青年委員會(huì)副主任委員,2021 年-2024 年 (3)山西省醫(yī)學(xué)會(huì)核醫(yī)學(xué)分會(huì),副主任委員,2020 年-至今 |